Contact us   |  

An article focused on the Patient (Advocate)’s Perspective on Biosimilars has been recently published!

An article focused on the Patient (Advocate)’s Perspective on Biosimilars has been recently published!

2022-03-28
An article focused on the Patient (Advocate)’s Perspective on Biosimilars has been recently published!

Maria Piggin, the ePAG representative of Paroxysmal Nocturnal Haemoglobinuria (PNH Support) in ERN-EuroBloodNet, is the author of the recently published article on HemaSphere Journal.

The involvement of patients' organizations in the Board of ERN-EuroBloodNet has been assured in order to guarantee their pivotal role within the network and keep ERN-EuroBloodNet patients' centred approach. The ERN-EuroBloodNet European Patient Advocacy Group (ePAG) is formed by 9 different patients Advocates who represent their disease area in the ERN-EuroBloodNet as well as the interests of the wider patient community affected by rare haematological diseases.

Maria Piggin, ePAG representative of Paroxysmal Nocturnal Haemoglobinuria (PNH Support) in ERN-EuroBloodNet, has recently published an article focused on the perspective on Biosimilars as a Patients Advocate and patient.

We invite you to read the article entitled, Addressing Inequality of Access to Biologics: What Is Your Role? A Patient (Advocate)'s Perspective on Biosimilars that has been published on HemaSphere.